clofibrate and probucol

clofibrate has been researched along with probucol in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	53 (73.61)	18.7374
1990's	16 (22.22)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (4.17)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, BJ; Barnhart, JW; Byers, C; Dull, RG; Mueller, LG; Renzi, AA; Rytter, DJ; Wagner, ER	1
Baader, E; Bartmann, W; Beck, G; Bergmann, A; Granzer, E; Jendralla, H; Kesseler, K; Krause, R; Schacht, U; von Kerekjarto, B	1
Aizawa, Y; Fujita, T; Hasegawa, K; Horikoshi, H; Kanai, T; Kurumada, T; Yoshioka, T	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Barnhart, JW; Molello, JA; Rytter, DJ	1
Avery, GS; Brogden, RN; Heel, RC; Speight, TM	1
Martz, BL	1
Fleischmajer, R	1
Kritchevsky, D	2
Itakura, H	1
Kłosiewicz-Latoszek, L; Szostak, WB	1
Hunninghake, DB	2
Huttunen, JK; Miettinen, TA; Naukkarinen, V; Strandberg, T; Vanhanen, H	1
Dostert, P; Hartmann, R; Oesch, F; Schladt, L; Strolin-Benedetti, M; Timms, C; Wörner, W	1
Islami, Y; Ribeiro, LG	1
Cravanzola, C; Franzone, JS; Pernigotti, ML; Reboani, MC; Torrielli, MV	1
Naito, HK	1
Kurasawa, T; Yamamoto, A; Yokoyama, S	1
Davignon, J	3
Blum, CB; Levy, RI	1
Nikkilä, EA; Tikkanen, MJ	1
Perry, RS	1
Havel, RJ; Kane, JP	1
Malinow, MR	1
Gotto, AM; Jones, PH; Scott, LW	1
Alaupovic, P; Bouthillier, D; Davignon, J; Nestruck, AC	1
Horie, S; Mitsukawa, M; Seki, K; Suga, T; Watanabe, T	1
Funahashi, T; Kishino, B; Matsuzawa, Y; Yamamoto, A; Yamamura, T; Yokoyama, S	1
Davignon, J; Nestruck, AC; Pande, SV	1
Krishnamurthy, A; Shridhar, DR; Thapar, GS	1
de Meglio, P; Gentili, P; Manzardo, S; Ravenna, F; Riva, M	1
Fumagalli, R; Paoletti, R; Sirtori, C	1
Dietschy, JM; Turley, SD	1
Donatelli, L	1
Santafé Oroz, J; Segarra Domènech, J	1
Glueck, C	1
Nash, DT	1
Harvengt, C; Heller, F	1
Kawecka-Jaszcz, K; Kocemba, J; Król, W; Wasowicz, B	1
Ehnholm, C; Huttunen, JK; Kumlin, T; Mattila, S; Miettinen, TA; Naukkarinen, V	1
Abiko, Y; Nakayasu, T; Tawara, K; Tomikawa, M	1
Davignon, J; Dubreuil-Quidoz, S; LeLorier, J; Lussier-Cacan, S	1
LaRosa, JC	1
Baraldi, G; Biso, P; Cavazzini, MG; De Benedittis, G; Labò, G; Melchionda, N; Parenti, M; Pasquali, R; Sorrenti, G	1
Samuel, P	1
Holets, RJ; Kottke, BA; Li, JR	1
Barnard, SD; Caldwell, WJ; LeBeau, JE; Molello, JA	2
Albengres, E; Choisy, H; Millart, H; Tillement, JP	1
Pignard, P	1
Leutenegger, M	1
Shand, JH; West, DW	3
Gotto, AM; Yeshurun, D	1
Gil, MJ; Monreal, JI; Rivero, A	1
Aberg, F; Appelkvist, EL; Dallner, G; Zhang, Y	1
Ades, EW; Lawley, TJ; Pruckler, JM	1
Auwerx, J; Fruchart, JC; Staels, B; Van Tol, A	1
Aragane, K; Kitamine, T; Kusunoki, J; Ohnishi, H; Yamaura, T	1

Reviews

16 review(s) available for clofibrate and probucol

Article	Year
Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia. Drugs, 1978, Volume: 15, Issue:6 Topics: Animals; Arteriosclerosis; Clofibrate; Dogs; Humans; Hypercholesterolemia; Hyperlipidemias; Kinetics; Phenols; Probucol; Rats	1978
Newer hypolipidemic compounds. Advances in experimental medicine and biology, 1975, Volume: 63 Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Clofibrate; Halofenate; Humans; Hypolipidemic Agents; Probucol; Rabbits; Rats; Structure-Activity Relationship; Triglycerides; Uric Acid	1975
Drug treatment of dyslipoproteinemia. Endocrinology and metabolism clinics of North America, 1990, Volume: 19, Issue:2 Topics: Bile Acids and Salts; Clofibrate; Coronary Disease; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipoproteinemias; Niacin; Probucol	1990
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines. Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1 Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Male; Probucol; Triglycerides	1988
Reducing cardiac deaths with hypolipidemic drugs. Postgraduate medicine, 1987, Nov-01, Volume: 82, Issue:6 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol	1987
Contemporary recommendations for evaluating and treating hyperlipidemia. Clinical pharmacy, 1986, Volume: 5, Issue:2 Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol	1986
Treatment of hypercholesterolemia. Annual review of medicine, 1986, Volume: 37 Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats	1986
The diagnosis and management of hyperlipidemia. Disease-a-month : DM, 1986, Volume: 32, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides	1986
Severe hypoalphalipoproteinemia induced by a combination of probucol and clofibrate. Advances in experimental medicine and biology, 1986, Volume: 201 Topics: Apolipoproteins; Cholesterol, HDL; Clofibrate; Drug Interactions; Humans; Hypolipoproteinemias; Lipids; Lipoproteins; Lipoproteins, HDL; Middle Aged; Phenols; Probucol; Time Factors	1986
Hypolipidemic drugs. Advances in experimental medicine and biology, 1973, Volume: 38 Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides	1973
[Pharmacology of probucol. I]. La Clinica terapeutica, 1984, Mar-15, Volume: 108, Issue:5 Topics: Adult; Aged; Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry; Cholesterol; Clofibrate; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Lipoproteins, LDL; Liver; Macaca fascicularis; Middle Aged; Phenols; Phospholipids; Probucol; Rabbits; Rats; Saimiri; Triglycerides	1984
[Pharmacologic therapy of atherosclerosis (I). Current possibilities]. Medicina clinica, 1983, Nov-26, Volume: 81, Issue:17 Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Gemfibrozil; Glycosaminoglycans; Humans; Ion Exchange Resins; Lipoproteins; Nicotinic Acids; Pentanoic Acids; Probucol	1983
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation, 1984, Volume: 69, Issue:5 Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lactation; Lipoproteins; Lovastatin; Naphthalenes; Niacin; Pentanoic Acids; Pregnancy; Pregnancy Complications; Probucol; Tangier Disease; Triglycerides	1984
[Diagnosis and treatment of primary hyperlipidemias]. Arquivos brasileiros de cardiologia, 1982, Volume: 38, Issue:1 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hyperlipidemia, Familial Combined; Male; Nicotinic Acids; Probucol; Triglycerides	1982
Hyperlipidemia: perspectives in diagnosis and treatment. Southern medical journal, 1995, Volume: 88, Issue:4 Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol; Risk; Triglycerides	1995
Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects. The American journal of cardiology, 1998, Apr-23, Volume: 81, Issue:8A Topics: Animals; Clofibrate; Drug Evaluation; Drug Evaluation, Preclinical; Drugs, Investigational; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Legislation, Drug; Probucol	1998

Trials

4 trial(s) available for clofibrate and probucol

Article	Year
Long-term use of probucol in the multifactorial primary prevention of vascular disease. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cerebrovascular Disorders; Cholesterol, HDL; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diuretics; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Phenols; Probucol; Risk; Smoking Prevention; Time Factors	1986
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines. Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1 Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Male; Probucol; Triglycerides	1988
[Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia]. Kardiologia polska, 1982, Volume: 25, Issue:5-6 Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Probucol	1982
Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apolipoproteins A-I and A-II. Atherosclerosis, 1980, Volume: 36, Issue:2 Topics: Antihypertensive Agents; Apolipoproteins; Body Weight; Cholesterol; Clofibrate; Humans; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins, HDL; Long-Term Care; Male; Probucol; Triglycerides	1980

Other Studies

53 other study(ies) available for clofibrate and probucol

Article	Year
Hypolipidemic arylthioalkanoic acids. Journal of medicinal chemistry, 1977, Volume: 20, Issue:8 Topics: Animals; Carboxylic Acids; Cholesterol; Hypolipidemic Agents; Liver; Male; Organ Size; Rats; Structure-Activity Relationship; Sulfides; Triglycerides	1977
Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids. Journal of medicinal chemistry, 1991, Volume: 34, Issue:10 Topics: Animals; Anticholesteremic Agents; Caproates; Carcinoma, Hepatocellular; Cholesterol; Dogs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Liver; Liver Neoplasms; Lovastatin; Male; Molecular Structure; Rabbits; Rats; Structure-Activity Relationship; Tumor Cells, Cultured	1991
Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. Journal of medicinal chemistry, 1989, Volume: 32, Issue:2 Topics: Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Peroxidation; Male; Mice; Mice, Inbred BALB C; Phenols; Rats; Structure-Activity Relationship	1989
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
An overview of the biochemical pharmacology of probucol. Lipids, 1977, Volume: 12, Issue:1 Topics: Animals; Aspartate Aminotransferases; Bile Acids and Salts; Catalase; Cholesterol; Clofibrate; Glucose-6-Phosphatase; Glutamate Dehydrogenase; Haplorhini; L-Lactate Dehydrogenase; Liver; Liver Glycogen; Macaca fascicularis; Male; Mice; Phenols; Probucol; Rats; Sterols	1977
Drug management of hypercholesterolemia. American heart journal, 1979, Volume: 97, Issue:3 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols	1979
Hypolipidemic drugs. American family physician, 1978, Volume: 17, Issue:2 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Probucol	1978
[Treatment of hyperlipidemia]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Nov-10, Volume: 81, Issue:11 Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dietary Fiber; Energy Intake; Female; Humans; Hyperlipidemias; Male; Niceritrol; Pravastatin; Probucol	1992
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1991, Jan-11, Volume: 33, Issue:835 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol	1991
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. European journal of clinical pharmacology, 1991, Volume: 40, Issue:1 Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol	1991
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds. Biochemical pharmacology, 1987, Feb-01, Volume: 36, Issue:3 Topics: Animals; Aspirin; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Enzyme Induction; Epoxide Hydrolases; Fatty Alcohols; Fenofibrate; Hepatomegaly; Hypolipidemic Agents; Imidazoles; Liver; Male; Microbodies; Microsomes, Liver; Oxidation-Reduction; Palmitoyl-CoA Hydrolase; Probucol; Rats; Rats, Inbred F344	1987
Biological properties of pancreatic elastase in relation to atherosclerotic disease. International journal of tissue reactions, 1988, Volume: 10, Issue:4 Topics: Animals; Antacids; Arteriosclerosis; Calcium; Citrates; Citric Acid; Clofibrate; Diet, Atherogenic; Endothelium, Vascular; Erythrocyte Deformability; Fibrinolytic Agents; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Pancreas; Pancreatic Elastase; Platelet Aggregation Inhibitors; Probucol; Rats; Rats, Inbred Strains; Swine; Vitamin D	1988
A little more information about aggravation of probucol-induced HDL-reduction by clofibrate. Atherosclerosis, 1988, Volume: 70, Issue:1-2 Topics: Adult; Aged; Bezafibrate; Cholesterol, HDL; Clofibrate; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lipoproteins, HDL; Male; Middle Aged; Phenols; Probucol	1988
Medical management of hyperlipidemia and the role of probucol. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk	1986
Rational drug therapy of the hyperlipoproteinemias, Part II. Rational drug therapy, 1986, Volume: 20, Issue:10 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol	1986
Current pharmacologic treatment of elevated serum cholesterol. Circulation, 1987, Volume: 76, Issue:3 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides	1987
Adverse effects of the treatment for hyperlipidemia. Cardiology clinics, 1986, Volume: 4, Issue:1 Topics: Anion Exchange Resins; Anticholesteremic Agents; Bibliographies as Topic; Clofibrate; Diet; Drug Therapy, Combination; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Physical Exertion; Probucol; Risk	1986
Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate. Journal of pharmacobio-dynamics, 1987, Volume: 10, Issue:3 Topics: Animals; Cell Division; Clofibrate; Glycolates; Hypolipidemic Agents; Lipids; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Nicotinic Acids; Phenoxyacetates; Probucol; Rats; Rats, Inbred Strains	1987
Effects of probucol on xanthomata regression in familial hypercholesterolemia. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Achilles Tendon; Adolescent; Adult; Aged; Anticholesteremic Agents; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Phenols; Plasmapheresis; Probucol; Xanthomatosis	1986
Addition to labeling of cholestyramine. FDA drug bulletin, 1985, Volume: 15, Issue:1 Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Drug Labeling; Gemfibrozil; Humans; Hypolipidemic Agents; Niacin; Pentanoic Acids; Probucol; Thyroxine; United States; United States Food and Drug Administration	1985
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1985, Aug-30, Volume: 27, Issue:695 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides	1985
Plasma carnitine and lipid-lowering drugs. Atherosclerosis, 1985, Volume: 55, Issue:3 Topics: Carnitine; Cholesterol, HDL; Clofibrate; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Probucol; Triglycerides	1985
Effect of probucol on triton induced hyperlipidemias in CFY rats. Artery, 1985, Volume: 13, Issue:2 Topics: Animals; Cholesterol; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Male; Phenols; Polyethylene Glycols; Probucol; Rats; Triglycerides	1985
[New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity]. Il Farmaco; edizione scientifica, 1985, Volume: 40, Issue:11 Topics: Animals; Chemical Phenomena; Chemistry; Clofibrate; Hyperlipidemias; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Phenols; Polyethylene Glycols; Probucol; Rats; Rats, Inbred Strains	1985
Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat. Journal of cardiovascular pharmacology, 1980, Volume: 2, Issue:3 Topics: Animals; Anticholesteremic Agents; Bile; Butyrates; Cholesterol; Cholestyramine Resin; Clofibrate; Female; Fluorenes; Intestines; Lipid Metabolism; Liver; Polymers; Probucol; Rats; Succinates	1980
Influence of clofibrate, bile-sequestering agents and probucol on high-density lipoprotein levels. The American journal of cardiology, 1983, Aug-22, Volume: 52, Issue:4 Topics: Bile Acids and Salts; Clofibrate; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Nicotinic Acids; Pentanoic Acids; Phenols; Probucol	1983
Hyperlipidemia: reducing the chances of cardiovascular disease. Geriatrics, 1984, Volume: 39, Issue:7 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Pentanoic Acids; Probucol; Triglycerides	1984
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects. European journal of clinical pharmacology, 1983, Volume: 25, Issue:1 Topics: Adult; Bezafibrate; Cholesterol; Clofibrate; Fenofibrate; Humans; Hypolipidemic Agents; Lipase; Lipolysis; Lipoprotein Lipase; Male; Phosphatidylcholine-Sterol O-Acyltransferase; Probucol; Triglycerides	1983
Probucol-lipid pharmacology. Artery, 1982, Volume: 10, Issue:1 Topics: Animals; Arteriosclerosis; Cholesterol; Clofibrate; Feces; Haplorhini; Humans; Lipid Metabolism; Lipids; Macaca fascicularis; Mice; Phenols; Probucol; Rabbits; Rats; Steroids	1982
Pharmacologic therapy for the hyperlipidemic patient. The American journal of medicine, 1983, May-23, Volume: 74, Issue:5A Topics: Bile Acids and Salts; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Niacin; Probucol	1983
Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice. Atherosclerosis, 1981, Volume: 40, Issue:2 Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Dose-Response Relationship, Drug; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Phenols; Probucol	1981
Experience with probucol in the treatment of hypercholesterolemia. Artery, 1982, Volume: 10, Issue:1 Topics: Cholesterol; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Patient Compliance; Phenols; Probucol	1982
The mechanism of action of lipid-lowering drugs. Angiology, 1982, Volume: 33, Issue:9 Topics: Cholestyramine Resin; Chylomicrons; Clofibrate; Fatty Acids; Hypolipidemic Agents; Lipid Metabolism; Lipolysis; Lipoprotein Lipase; Lipoproteins; Nicotinic Acids; Probucol	1982
[Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia]. La Clinica terapeutica, 1982, Dec-15, Volume: 103, Issue:5 Topics: Adult; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Probucol	1982
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1980, Aug-08, Volume: 22, Issue:16 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Probucol	1980
Drug treatment of hyperlipidemia. American heart journal, 1980, Volume: 100, Issue:4 Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol	1980
Effect of probucol on cholesterol metabolism in the rat. Atherosclerosis, 1980, Volume: 36, Issue:4 Topics: Animals; Body Weight; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Clofibrate; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Liver; Male; Organ Size; Phenols; Probucol; Rats	1980
Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate. Journal of toxicology and environmental health, 1980, Volume: 6, Issue:3 Topics: Animals; Cholesterol; Clofibrate; Female; Liver; Male; Phenols; Probucol; Rats	1980
[Hypolipidaemic agents (author's transl)]. La Nouvelle presse medicale, 1980, Oct-30, Volume: 9, Issue:40 Topics: Animals; Chemical Phenomena; Chemistry; Cholesterol; Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Nicotinic Acids; Probucol	1980
[Probucol: chemical structure, physical properties and assay methods (author's transl)]. La Nouvelle presse medicale, 1980, Oct-30, Volume: 9, Issue:40 Topics: Chemical Phenomena; Chemistry; Chromatography, Gas; Chromatography, High Pressure Liquid; Clofibrate; Humans; Phenols; Probucol; Spectrophotometry, Ultraviolet	1980
[The effects of probucol in man (author's transl)]. La Nouvelle presse medicale, 1980, Oct-30, Volume: 9, Issue:40 Topics: Anticholesteremic Agents; Arteriosclerosis; Bile; Clofibrate; Electrocardiography; Heart; Humans; Hyperlipoproteinemia Type II; Phenols; Probucol	1980
[Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)]. La Nouvelle presse medicale, 1980, Oct-30, Volume: 9, Issue:40 Topics: Animals; Body Weight; Clofibrate; Fenofibrate; Hypolipidemic Agents; Lipids; Liver; Microbodies; Microscopy, Electron; Phenols; Probucol; Propionates; Rats	1980
The effects of probucol and clofibrate alone and in combination on hepatic cholesterol metabolism in the male rat. Biochimica et biophysica acta, 1995, Mar-16, Volume: 1255, Issue:2 Topics: Animals; Body Weight; Cholesterol; Clofibrate; Cytosol; Lipid Metabolism; Lipids; Liver; Male; Microsomes, Liver; Organ Size; Probucol; Rats; Rats, Wistar; Sterol Esterase; Sterol O-Acyltransferase	1995
Inhibition of neutral cholesterol ester hydrolase in rat liver by fibric acids and probucol in vitro. Biochemical Society transactions, 1994, Volume: 22, Issue:4 Topics: Animals; Bezafibrate; Clofibrate; Cytosol; Kinetics; Liver; Male; Microsomes, Liver; Probucol; Rats; Sterol Esterase	1994
Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs. Revista espanola de fisiologia, 1994, Volume: 50, Issue:4 Topics: Acetyl-CoA C-Acetyltransferase; Acyl-CoA Oxidase; Animals; Anti-Inflammatory Agents; Aspirin; Base Sequence; Brain; Catalase; Clofibrate; Diflunisal; Hypolipidemic Agents; Lipid Peroxidation; Liver; Male; Microbodies; Molecular Sequence Data; Oxidative Stress; Oxidoreductases; Probucol; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Zinc	1994
The effect of probucol and clofibrate on hepatic cholesterol metabolism. Biochemical Society transactions, 1994, Volume: 22, Issue:2 Topics: Animals; Cholesterol; Clofibrate; Liver; Male; Probucol; Rats; Rats, Wistar; Sterol Esterase; Sterol O-Acyltransferase	1994
Effects of clofibrate, phthalates and probucol on ubiquinone levels. Chemico-biological interactions, 1994, Volume: 91, Issue:1 Topics: Animals; Brain; Cholesterol; Chromatography, High Pressure Liquid; Clofibrate; Diet; Diethylhexyl Phthalate; Dolichols; Liver; Male; Mevalonic Acid; Muscles; Myocardium; Oxidation-Reduction; Probucol; Rats; Rats, Sprague-Dawley; Ubiquinone	1994
Use of a human microvascular endothelial cell line as a model system to evaluate cholesterol uptake. Pathobiology : journal of immunopathology, molecular and cellular biology, 1993, Volume: 61, Issue:5-6 Topics: Biological Transport; Cells, Cultured; Cholesterol; Cholestyramine Resin; Clofibrate; Endothelium, Vascular; Gemfibrozil; Humans; Models, Biological; Probucol; Tritium	1993
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1993, Mar-05, Volume: 35, Issue:891 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol	1993
Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat. Israel journal of medical sciences, 1996, Volume: 32, Issue:6 Topics: Actins; Animals; Apolipoproteins; Cholestyramine Resin; Clofibrate; Fenofibrate; Gene Expression Regulation; Hypolipidemic Agents; Intestinal Mucosa; Lipid Metabolism; Lipoproteins, HDL; Liver; Lovastatin; Male; Niacin; Probucol; Rats; Rats, Wistar; Simvastatin	1996
[Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1997, Volume: 110, Issue:6 Topics: Anilides; Anticholesteremic Agents; Caco-2 Cells; Cholesterol; Cholesterol Esters; Clofibrate; Cyclohexanes; Dioxanes; Esterification; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Phenylurea Compounds; Pravastatin; Probucol; Simvastatin; Sterol O-Acyltransferase	1997